Inventor

SCHLEMMER KARL-HEINZ

DE120 patents

⚠️ This page may combine multiple inventors who share the name “SCHLEMMER KARL-HEINZ”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SCHLEMMER KARL-HEINZ

BAYER AG

2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors

2-phenyl substituted imidatriazinones as phosphodiesterase inhibitors

1,5-dihydro-pyrazolo[34-D]-pyrimidinone derivatives

7-alkyl- and cycloalkyl-substituted imidazotriazinones

Dihydro-[1,2,3]triazolo-[4,5-d]pyrimidin-7-one

2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors, for treatment of hypertension

Substituted oxazolidinones and their use in the field of blood coagulation

Substituted imidazotriazinones

3-oxo-2,1-benzisoxazol-1(3H)-carboxamides for treatment of CNS diseases

Dihydropyrimidines

Substituted imidazotriazinones

BAYER SCHERING PHARMA AG

Substituted oxazolidinones and their use in the field of blood coagulation

2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors

Substituted oxazolidinones and their use in the field of blood coagulation

Substituted oxazolidinones and their use in the field of blood coagulation

Biphenyl compounds useful in the treatment or prevention of cardiovascular disorders

Substituted oxazolidinones for combinational therapy

Heterocyclic derivatives

Dihydropyridine derivatives for use as human neutrophil elastase inhibitors

2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors

BAYER HEALTHCARE AG

Substituted oxazolidinones and their use in the field of blood coagulation

2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors

Substituted imidazotriazines

2-Phenyl substituted imidazotriazinones as phosphodiesterase inhibitors

Imidazo[1,3,5]triazinones and their use

Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes

1-phenyl1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use

Imidazotriazines for use as phosphodiesterase inhibitors

Bayer Pharma AG

Substituted oxopyridine derivatives and use thereof cardiovascular disorders

Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders

Substituted oxopyridine derivatives and use thereof as factor xia/plasma

Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders

(Aza)pyridopyrazolopyrimidinones and indazolopyrimidinones and their use

BAYER IP GMBH

Substituted 5-fluoro-1H-pyrazolopyridines and their use

Substituted 5-fluoro-1H-pyrazolopyridines and their use

Branched 3-phenylpropionic acid derivatives and their use

FOLLMANN MARKUS

Substituted 5-fluoro-1H-pyrazolopyridines and their use

Substituted 6-fluoro-1H-pyrazolo[4,3-b]pyridines and use thereof

ADVERIO PHARMA GMBH

Substituted 5-flouro-1H-pyrazolopyridines and their use

Substituted 5-fluoro-1H-pyrazolopyridines and their use

SCHIROK HARTMUT

Pyrazolopyridine, indazole, imidazopyridine, imidazopyrimidine, pyrazolopyrazine and pyrazolopyridine derivatives as stimulators of guanylate cyclase for cardiovascular disorders

HAHN MICHAEL

Branched 3-phenylpropionic acid derivatives and their use

BAERFACKER LARS

Substituted-4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof

GOLDMANN SIEGFRIED

Medicaments against viral diseases

BOESS FRANK-GERHARD

Selective PDE 2 inhibitors as pharmaceuticals for improving perception

BAYER AKTLENGESELLSCHAFT

Imidazo[1,3,5]triazinones and the use thereof

LERCHEN HANS-GEORG

Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders

BAYER PHARMACEUTICALS CORP

Pyrrolo (2.1a)dihydroisoquinolines and their use as phosphodiesterase 10a inhibitors

FIGUEROA PEREZ SANTIAGO

Aryl-or heteroaryl-substituted pyrido[2,3-d] pyrimidines and pharmaceutical compositions of the same

HUEBSCH WALTER

Substituted 8-alkoxy-2-aminotetralin derivatives, and use thereof